Results 11 to 20 of about 93,339 (287)
Age-related macular degeneration
Clinical Ophthalmology, 2011 Giuseppe Querques¹, Fernando Onofrio Avellis1,2, Lea Querques1,3, Francesco Bandello³, Eric H Souied¹ ¹Service d'Ophtalmologie, Centre Hospitalier Intercommunal Créteil, Université Paris ...
Querques G +4 more
doaj +5 more sources
Age-related macular degeneration
Community Eye Health Journal, 2014 Age-related macular degeneration (AMD) is a disease of the retina that usually develops in people aged 60 years and older. It affects about 8.7% of the world’s population and is the leading cause of blindness among people aged 50 and older in ...
Wanjiku Mathenge
doaj +4 more sources
Age-Related Macular Degeneration: Classification and Pathogenesis
Türk Oftalmoloji Dergisi, 2014 Age-related macular degeneration (AMD) was first described in 1885 by Otto Haab as a disease in patients above 50 years of age with progressive retinal pigment epithelial and atrophic degenerations of the macula reducing the central visual acuity.
İmren Akkoyun
doaj +2 more sources
Age-related macular degeneration: current treatments [PDF]
Clinical Ophthalmology, 2009 Jean Pierre Hubschman, Shantan Reddy, Steven D SchwartzJules Stein Eye Institute, Department of Ophthalmology, University of California, David Geffen School of Medicine, Los Angeles, California, USAPurpose: Although important progress has been made in ...
Jean Pierre Hubschman +2 more
doaj +2 more sources
Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci. [PDF]
PLoS ONE, 2018 Late-stage age-related macular degeneration (AMD) is the leading cause of visual impairment in the elderly with a complex etiology. The most important non-modifiable risk factors for onset and progression of late AMD are age and genetic risk factors ...
Thomas W Winkler +8 more
doaj +3 more sources
Age-related macular degeneration: experimental and emerging treatments [PDF]
Clinical Ophthalmology, 2009 Jean Pierre Hubschman, Shantan Reddy, Steven D SchwartzJules Stein Eye Institute, Department of Ophthalmology, University of California, David Geffen School of Medicine, Los Angeles, California, USAPurpose: This essay reviews the experimental treatments ...
Jean Pierre Hubschman +2 more
doaj +2 more sources
Age-related macular degeneration [PDF]
Journal of the Royal Society of Medicine, 2009 Age-related macular degeneration (AMD) is a significant source of morbidity in aging adults. The damage to the macula and vision loss in advanced forms of wet AMD stems from choroidal neovascularization that originates in the choroid and proliferates through breaks in the Bruch membrane. Although inhibitors of angiogenesis have been a recent advance in
Tariq, Ayoub, Nishal, Patel
+6 more sources
Age-related macular degeneration [PDF]
British Menopause Society Journal, 2006 Age-related macular degeneration is a common cause of blindness. Its incidence is increasing, partly due to the advancing age of the population in North America and Europe, but there is no doubt that the age-adjusted rates are also increasing, which points to some environmental influence.
Amod Gupta, Vishali Gupta, Mangat Dogra
+9 more sources
Radiation therapy for neovascular age-related macular degeneration
Clinical Ophthalmology, 2011 Robert Petrarca, Timothy L JacksonDepartment of Ophthalmology, King’s College Hospital NHS Foundation Trust, London, UKAbstract: Antivascular endothelial growth factor (anti-VEGF) therapies represent the standard of care for most patients ...
Robert Petrarca, Timothy L Jackson
doaj +2 more sources
Modelling the Genetic Risk in Age-Related Macular Degeneration [PDF]
, 2012 Late-stage age-related macular degeneration (AMD) is a common sight-threatening disease of the central retina affecting approximately 1 in 30 Caucasians.
Weber, Bernhard H. F. +29 more
core +1 more source